Penumbra ( (PEN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Penumbra shares are sliding as investors reassess the terms of its proposed $14.5 billion takeover by Boston Scientific, announced yesterday. The deal’s value is being dragged down because Boston Scientific’s own stock has dropped, weakening the stock-based part of the offer and leaving Penumbra trading well below the touted $374 per share.
Selling pressure has intensified as several law firms launch probes into whether the merger terms are fair to Penumbra shareholders. The mood has darkened further after analysts cut their ratings to neutral, arguing that with the takeover price effectively capping future gains, the stock’s upside now looks limited.
More about Penumbra
YTD Price Performance: 6.10%
Average Trading Volume: 1,058,423
Technical Sentiment Signal: Buy
Current Market Cap: $12.95B
For further insights into PEN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.